English | Español

Eli Lilly And Company
Patient Daily | May 25, 2023

Lilly ESG Report Highlights Progress Towards Sustainability Goals
Patient Daily | May 24, 2023

Lilly's peresolimab Phase 2a rheumatoid arthritis trial published in The New England Journal of Medicine
Patient Daily | May 22, 2023

Loxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting
Patient Daily | May 9, 2023

Lilly Provides $500,000 in Grants to Support Equitable Access to Education for Dreamers in Indiana
Patient Daily | May 9, 2023

Lilly Declares Second-Quarter 2023 Dividend
Patient Daily | May 9, 2023

Lilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in SURMOUNT-2
Patient Daily | Apr 26, 2023

Lilly to Divest BAQSIMI to Amphastar
Patient Daily | Apr 26, 2023

Lilly to Make Record-Breaking Investment in Indiana Manufacturing Facilities

Trending
+ Regulatory
Patient Daily News Service | Jan 12, 2025

National Consumers League CEO: Federal 340b drug discount program ‘hijacked by hospitals and contract pharmacies’
+ Regulatory
Patient Daily News Service | Jan 16, 2025

FTC Chair: Report Finds 'Three Major Pharmacy Benefit Managers Hiked Costs for a Wide Range of Lifesaving Drugs, Including Medications to Treat Heart Disease and Cancer'
+ Pharmaceuticals
Patient Daily | Jan 15, 2025

Dr. Peter Hotez receives 2025 Hill Prize for public health innovations
+ Regulatory
Patient Daily reports | Jan 14, 2025

National health reform group: 'Plenty of evidence that hospitals are not passing along' discounted drug prices under 340b program